ClinicalTrials.govpublic full text
In Vitro Expanded Allogeneic Epstein-Barr Virus Specific Cytotoxic T-Lymphocytes (EBV-CTLs) Genetically Targeted to the CD19 Antigen in B-cell Malignancies
acute lymphocytic leukemia, lymphoma, in vitro expanded allogeneic epstein-barr virus specific cytotoxic, t-lymphocytes (ebv-ctls), cd19 specific t-cells, 11-038, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 800465
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.